| SC 13G | 2015-02-17 | NOVO NORDISK A S | Affimed N.V. | 2,734,014 | 11.4% | EDGAR |
| SC 13G | 2015-02-12 | WELLINGTON MANAGEMENT GROUP LLP | Affimed N.V. | 1,947,631 | 8.1% | EDGAR |
| SC 13D | 2014-09-24 | KfW | Affimed N.V. | 335,276 | 1.4% | EDGAR |
| SC 13D/A | 2014-09-23 | Little Melvyn | Affimed N.V. | 151,080 | 0.6% | EDGAR |
| SC 13D | 2014-09-23 | Technology Participation Co | Affimed N.V. | 300,400 | 1.3% | EDGAR |
| SC 13D | 2014-09-23 | German Cancer Research Center | Affimed N.V. | 28,001 | 0.1% | EDGAR |
| SC 13D | 2014-09-22 | NOVO NORDISK A S | Affimed N.V. | 2,734,014 | 11.4% | EDGAR |
| SC 13D | 2014-09-22 | Little Melvyn | Affimed N.V. | - | - | EDGAR |
| SC 13D | 2014-09-22 | BioMedInvest I Ltd. | Affimed N.V. | 1 | 6.5% | EDGAR |
| SC 13D | 2014-09-22 | LSP III Omni Investment Cooperatief U.A. | Affimed N.V. | 1,561,403 | 6.5% | EDGAR |
| SC 13D | 2014-09-22 | SGR Sagittarius Holding AG | Affimed N.V. | 5,334,397 | 22.2% | EDGAR |
| SC 13D | 2014-09-19 | ORBIMED ADVISORS LLC | Affimed N.V. | 5,814,630 | 24.2% | EDGAR |